NEW YORK, Aug. 29 – British DNA sequencer Whatman and Dutch firms PamGene and Plant Research International have entered into a three-way, four-year partnership to develop rapid assays for agrotechnology, the companies announced on Wednesday.

The research, which will be conducted in Plant Research’s labs, will rely on PamGene’s PamChip microarray technology and Whatman’s nucleic acid isolation technology.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.